Localization and activity of iNOS in normal human lung tissue and lung cancer tissue.

Inducible nitric oxide synthase (iNOS) is one of three enzymes generating nitric oxide (NO) from the amino acid L-arginine. iNOS-derived NO plays an important role in several physiological and pathophysiological conditions. NO is a free radical which produces many reactive intermediates that account for its bioactivity. In the human lung, the alveolar macrophage is an important producer of cytokines and this production may be modified by NO. Moreover, high concentrations of NO have been shown to increase nuclear factor chiB (NF-kB) activation. Recent investigations of NO expression in tumor tissue indicated that, at least for certain tumors, NO may mediate one or more roles during the growth of human cancer. We have studied iNOS in two tissue groups: normal human lung tissue and human lung cancer tissue. We localized iNOS in these tissues by immunohistochemistry and tested the mRNA expression by RT-PCR, the protein level by Western blot, and the protein activity by radiometric analysis. The results demonstrate different expression, localization and activity of iNOS in normal versus tumor tissue. This is suggestive of a role for NO production from iNOS in human lung cancer because high concentrations of this short molecule may transform to highly reactive compounds such as peroxynitrite (ONOO-); moreover, through the upregulator NF-kB, they can induce a chronic inflammatory state representing an elevated risk for cell transformation to cancer.

[1]  Sanjay Kumar,et al.  IL-13 Neutralization Modulates Function of Type II Polarized Macrophages in vivo in a Murine T-Cell Lymphoma , 2007 .

[2]  S. Vakalopoulou,et al.  Acute Leukemia and Pregnancy , 2007 .

[3]  T. Theoharides,et al.  Glaucoma: Current and Developing Concepts for Inflammation, Pathogenesis and Treatment , 2006 .

[4]  Robert B Sim,et al.  Discrete MBL-MASP Complexes Show Wide Inter-Individual Variability in Concentration: Data from UK vs Armenian Populations , 2006, International journal of immunopathology and pharmacology.

[5]  J. Turnbull,et al.  A Study of the Purine Derivative AIT-082 in G93A SOD1 Transgenic Mice , 2006, International journal of immunopathology and pharmacology.

[6]  G. de Rosa,et al.  Genetic Analysis of Oral Squamous Cell Carcinoma by cDNA Microarrays Focused Apoptotic Pathway , 2006, International journal of immunopathology and pharmacology.

[7]  P. Poindron,et al.  The Role of Calcium and Magnesium Ions in Uptake of β-Amyloid Peptides by Microglial Cells , 2006, International journal of immunopathology and pharmacology.

[8]  C. Palumbo,et al.  Immunity to Extracellular Matrix Antigens is Associated with Ultrastructural Alterations of the Stroma and Stratified Epithelium Basement Membrane in the Skin of Hashimoto's Thyroiditis Patients , 2006, International journal of immunopathology and pharmacology.

[9]  G. Dveksler,et al.  Peroxiredoxin Genes are Not Induced in Myeloid Leukemia Cells Exposed to Ionizing Radiation , 2006, International journal of immunopathology and pharmacology.

[10]  A. Cottarelli,et al.  In Vivo Effect of an Immunostimulating Bacterial Lysate on Human B Lymphocytes , 2006, International journal of immunopathology and pharmacology.

[11]  S. Caputi,et al.  Adult Mesenchymal Stem Cells in Dental Research: A New Approach for Tissue Engineering , 2006, International journal of immunopathology and pharmacology.

[12]  M. Viola-Magni,et al.  Low Levels of Serum Cholesterol/Phospholipids are Associated with the Antiphospholipid Antibodies in Monoclonal Gammopathy , 2006, International journal of immunopathology and pharmacology.

[13]  G. Maira,et al.  Intracerebral Diffusion of Paramagnetic Cationic Liposomes Containing Gd(DTPA)2- Followed by MRI Spectroscopy: Assessment of Patternc Diffusion and Time Steadiness of a Non-Viral Vector Model , 2006, International journal of immunopathology and pharmacology.

[14]  M. L. Castellani,et al.  The Proinflammatory Interleukin-21 Elicits Anti-Tumor Response and Mediates Autoimmunity , 2006, International journal of immunopathology and pharmacology.

[15]  H. Lorenz,et al.  Leukocyte Infiltration and mRNA Expression of IL-20, IL-8 and TNF-R p60 in Psoriatic Skin is Driven by TNF-α , 2006, International journal of immunopathology and pharmacology.

[16]  M. Delfino,et al.  Role of Pegylated Lyposomal Doxorubicin (PLD) in Systemic Kaposi's Sarcoma: A Systematic Review , 2006, International journal of immunopathology and pharmacology.

[17]  J. A. Maier,et al.  Impact of Simulated Microgravity on Cell Cycle Control and Cytokine Release by U937 Cells , 2006, International journal of immunopathology and pharmacology.

[18]  M. Rathbone,et al.  P2Y2 Receptor Up-Regulation Induced by Guanosine or UTP in Rat Brain Cultured Astrocytes , 2006, International journal of immunopathology and pharmacology.

[19]  Sanjay Kumar,et al.  Heat Shock Proteins (HSP): Future Trends in Cancer Immunotherapy , 2006 .

[20]  P. Lirk,et al.  Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. , 2005, Seminars in cancer biology.

[21]  A. Cataldi,et al.  Effect of Chronic Hypoxia on Inducible Nitric Oxide Synthase Expression in Rat Myocardial Tissue , 2003, Experimental biology and medicine.

[22]  R. de Caterina,et al.  Inducible nitric oxide synthase and heme oxygenase-1 in rat heart: direct effect of chronic exposure to hypoxia. , 2003, Annals of clinical and laboratory science.

[23]  F. Fitzpatrick,et al.  Inflammation, carcinogenesis and cancer. , 2001, International immunopharmacology.

[24]  M. Kavuru,et al.  Human alveolar macrophages and monocytes as a source and target for nitric oxide. , 2001, International immunopharmacology.

[25]  P K Lala,et al.  Role of nitric oxide in carcinogenesis and tumour progression. , 2001, The Lancet. Oncology.

[26]  A. Grilli,et al.  Localization of the e-NOS enzyme in endothelial cells and odontoblasts of healthy human dental pulp. , 2000, Life sciences.

[27]  J. Bertram,et al.  Molecular Biology of Cancer , 1997, Nature Medicine.

[28]  J. Mcgregor,et al.  Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells. , 2000, Cellular immunology.

[29]  A. Arroliga,et al.  Nitric Oxide Blocks Nuclear Factor- κ B Activation in Alveolar Macrophages , 1999 .

[30]  I. Macara,et al.  Cooperativity between Oxidants and Tumor Necrosis Factor in the Activation of Nuclear Factor (NF)- κ B , 1999 .

[31]  David A. Geller,et al.  Multiple NF-κB Enhancer Elements Regulate Cytokine Induction of the Human Inducible Nitric Oxide Synthase Gene* , 1998, The Journal of Biological Chemistry.

[32]  D. Laskowski,et al.  Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. , 1998, The Journal of clinical investigation.

[33]  H. Abe,et al.  Nitric oxide as a carcinogen: analysis by yeast functional assay of inactivating p53 mutations induced by nitric oxide. , 1997, Mutation research.

[34]  G. Wogan,et al.  Mutagenesis associated with nitric oxide production in transgenic SJL mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  T. Aas,et al.  Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients , 1996, Nature Medicine.

[36]  P Rhodes,et al.  Roles of nitric oxide in tumor growth. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Tannenbaum,et al.  Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. , 1995, Chemical research in toxicology.

[38]  H. Bartsch,et al.  Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. , 1994, Mutation research.

[39]  C. Nathan,et al.  Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. , 1994, The Journal of biological chemistry.

[40]  J. Stamler,et al.  Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. , 1993, American journal of respiratory cell and molecular biology.

[41]  R. C. Garner,et al.  Correlation of DNA adduct levels in human lung with cigarette smoking , 1988, Nature.

[42]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[43]  C. de Dominicis,et al.  Encrusted cystitis in an immunocompromised patient: possible coinfection by Corynebacterium urealyticum and E. coli. , 2006, International journal of immunopathology and pharmacology.

[44]  A. Pries,et al.  Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo. , 2006, International journal of immunopathology and pharmacology.

[45]  N. Siafakas,et al.  Angiogenic molecules in Hodgkin's disease: results from sequential serum analysis. , 2006, International journal of immunopathology and pharmacology.

[46]  C. Genchi,et al.  Detection of hepatitis C virus-RNA in saliva from chronically HCV-infected patients. , 2006, International journal of immunopathology and pharmacology.

[47]  M. L. Castellani,et al.  Interleukin-31: a new cytokine involved in inflammation of the skin. , 2006, International journal of immunopathology and pharmacology.

[48]  H. Nagawa,et al.  Surveillance colonoscopy should be conducted in patients with colorectal Shistosomiasis even after successful treatment of the disease. , 2006, International journal of immunopathology and pharmacology.

[49]  G. Marseglia,et al.  Inhaled tobramycin in children with acute bacterial rhinopharyngitis. , 2006, International journal of immunopathology and pharmacology.

[50]  I. D'Agnano,et al.  c-MYC deregulation is involved in melphalan resistance of multiple myeloma: role of PDGF-BB. , 2006, International journal of immunopathology and pharmacology.

[51]  N. Cassano,et al.  Infliximab in recalcitrant severe atopic eczema associated with contact allergy. , 2006, International journal of immunopathology and pharmacology.

[52]  M. Castagnola,et al.  Increased levels of IGF-1 and beta2-microglobulin in epithelial lining fluid of preterm newborns developing chronic lung disease. effects of rhG-CSF. , 2006, International journal of immunopathology and pharmacology.

[53]  L. Settas,et al.  Fibromyalgia--new concepts of pathogenesis and treatment. , 2006, International journal of immunopathology and pharmacology.

[54]  A. Pierangeli,et al.  Detection of human papillomavirus DNA, p53 and ki67 expression in penile carcinomas. , 2006, International journal of immunopathology and pharmacology.

[55]  J. Nesland,et al.  Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood. , 2006, International journal of immunopathology and pharmacology.

[56]  M. D’Elios,et al.  Soluble CD30 and lymphocyte activation gene-3 (CD223), as potential serological markers of T helper-type cytokine response induced by acellular pertussis vaccine. , 2006, International journal of immunopathology and pharmacology.

[57]  L. Bartalena,et al.  Thyroid hormone and thyrotropin regulate intracellular free calcium concentrations in human polymorphonuclear leukocytes: in vivo and in vitro studies. , 2006, International journal of immunopathology and pharmacology.

[58]  F. Marcucci,et al.  Sublingual reactivity to rBET V1 and rPHL P1 in patients with oral allergy syndrome. , 2006, International journal of immunopathology and pharmacology.

[59]  N. Cassano,et al.  Once-weekly administration of high-dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study). , 2006, International journal of immunopathology and pharmacology.

[60]  C. Mignogna,et al.  Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior? , 2006, International journal of immunopathology and pharmacology.

[61]  F. Midulla,et al.  Cytokines in the nasal washes of children with respiratory syncytial virus bronchiolitis. , 2006, International journal of immunopathology and pharmacology.

[62]  M. Blanca,et al.  T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence. , 2006, International journal of immunopathology and pharmacology.

[63]  A. Albini,et al.  The expression of CD154 by Kaposi's sarcoma cells mediates the anti-apoptotic and migratory effects of HIV-1-TAT protein. , 2006, International journal of immunopathology and pharmacology.

[64]  G. Lorenzo,et al.  Hormone refractory prostate cancer (HRPC): present and future approaches of therapy. , 2006 .

[65]  P. Shields,et al.  Molecular epidemiology of lung cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[66]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.